Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality. Mutation or dysexpression of the genes that disturb any finely regulated steps of ribosome biogenesis can result in different types of ribosomopathies in clinic, collectively known...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2024-03-01
|
| Sarja: | Journal of Pharmaceutical Analysis |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2095177923002599 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|